The effects of oral magnesium supplementation on glycemic response among type 2 diabetes patients

Nutrients

Volumn 11, Issue 1, 2019, Pages

  Elderawi, Wafaa A ^a   Naser, Ihab A ^a   Taleb, Mahmmoud H ^a   Abutair, Ayman S ^a  

^a AL AZHAR UNIVERSITY   (Palestine)

Author keywords

Blood glucose; Diabetes mellitus; Insulin; Magnesium

Indexed keywords

ALANINE AMINOTRANSFERASE; C PEPTIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; MAGNESIUM;

ADULT; ARTICLE; BIOCHEMICAL ANALYSIS; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TOTAL CHOLESTEROL LEVEL; BLOOD; DIETARY SUPPLEMENT; DRUG EFFECT; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNESIUM; MALE; MIDDLE AGED;

EID: 85059233365     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu11010044     Document Type: Article

References (27)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33 (Suppl. 1), S62–S69. [CrossRef] [PubMed]
2. Skyler, J.S. Diabetes mellitus: Pathogenesis and natural history. In Transplantation of the Pancreas; Springer: New York, NY, USA, 2004; pp. 11–27.
3. World Health Organization. Global Report on Diabetes; WHO: Geneva, Switzerland, 2016.
4. Mitri, J.; Pittas, A.G. Vitamin D and diabetes. Endocrinol. Metab. Clin. 2014, 43, 205–232. [CrossRef] [PubMed]
5. Hamed, A.T.; Al Zinati, S.M.; Al Swirky, A. The Effect of Vitamin C Alone or in Combination with Vitamin E on Fasting Blood Glucose, Glycosylated Hemoglobin and Lipid Profile in Type 2 Diabetic Patients (Gaza Strip). Jordan J. Pharm. Sci. 2016, 9, 1–12. [CrossRef]
6. Abutair, A.S.; Naser, I.A.; Hamed, A.T. Soluble fibers from psyllium improve glycemic response and body weight among diabetes type 2 patients (randomized control trial). Nutr. J. 2016, 15, 86. [CrossRef] [PubMed]
7. Rodrguez-Moran, M.; Menda, L.E.S.; Galvn, G.Z.; Guerrero-Romero, F. The role of magnesium in type 2 diabetes: A brief based-clinical review. Magnes. Res. 2011, 24, 156–162.
8. Solati, M.; Ouspid, E.; Hosseini, S.; Soltani, N.; Keshavarz, M.; Dehghani, M. Oral magnesium supplementation in type II diabetic patients. Med. J. Islam. Repub. Iran 2013, 28, 67.
9. Kolterman, O.G.; Gray, R.S.; Griffin, J.; Burstein, P.; Insel, J.; Scarlett, J.A.; Olefsky, J.M. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J. Clin. Investig. 1981, 68, 957–969. [CrossRef]
10. Dominguez, L.J.; Barbagallo, M.; Sowers, J.R.; Resnick, L.M. Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects. J. Clin. Endocrinol. Metab. 1998, 83, 4402–4407. [CrossRef]
11. Bergman, R.N.; Phillips, L.S.; Cobelli, C. Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Investig. 1981, 68, 1456–1467. [CrossRef]
12. Rodrguez-Morn, M.; Guerrero-Romero, F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care 2003, 26, 1147–1152. [CrossRef]
13. Guerrero Romero, F.; Rodrguez Morn, M. Magnesium improves the beta cell function to compensate variation of insulin sensitivity: Double blind, randomized clinical trial. Eur. J. Clin. Investig. 2011, 41, 405–410. [CrossRef] [PubMed]
14. Chacko, S.A.; Sul, J.; Song, Y.; Li, X.; LeBlanc, J.; You, Y.; Butch, A.; Liu, S. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: A randomized, double-blind, controlled, crossover trial in overweight individuals. Am. J. Clin. Nutr. 2011, 93, 463–473. [CrossRef] [PubMed]
15. De Valk, H.; Verkaaik, R.; Van Rijn, H.; Geerdink, R.; Struyvenberg, A. Oral magnesium supplementation in insulin requiring Type 2 diabetic patients. Diabet. Med. 1998, 15, 503–507. [CrossRef]
16. De Lourdes Lima, M.; Cruz, T.; Pousada, J.C.; Rodrigues, L.E.; Barbosa, K.; Cangu, V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998, 21, 682–686. [CrossRef]
17. Matthews, D.; Hosker, J.; Rudenski, A.; Naylor, B.; Treacher, D.; Turner, R. Homeostasis model assessment: Insulin resistance and-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412–419. [CrossRef] [PubMed]
18. Bo, S.; Pisu, E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr. Opin. Lipidol. 2008, 19, 50–56. [CrossRef]
19. Jahnen-Dechent, W.; Ketteler, M. Magnesium basics. Clin. Kidney J. 2012, 5 (Suppl. 1), i3–i14. [CrossRef]
20. Dai, Q.; Shu, X.-O.; Deng, X.; Xiang, Y.-B.; Li, H.; Yang, G.; Shrubsole, M.J.; Ji, B.; Cai, H.; Chow, W.H.; et al. Modifying effect of calcium/magnesium intake ratio and mortality: A population-based cohort study. BMJ Open 2013, 3, e002111.
21. Maguire, M.E.; Cowan, J.A. Magnesium chemistry and biochemistry. Biometals 2002, 15, 203–210. [CrossRef]
22. Guerrero-Romero, F.; Tamez-Perez, H.E.; González-González, G.E.; Salinas-Martinez, A.M.; Montes-Villarreal, J.; Trevino-Ortiz, J.H.; Rodriguez-Moran, M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004, 30, 253–258. [CrossRef]
23. Paolisso, G.; Barbagallo, M. Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium. Am. J. Hypertens. 1997, 10, 346–355. [CrossRef]
24. Takaya, J.; Higashino, H.; Kobayashi, Y. Intracellular magnesium and insulin resistance. Magnes. Res. 2004, 17, 126–136. [PubMed]
25. Shils, M.E.; Shike, M. Modern Nutrition in Health and Disease; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006.
26. Mooren, F.; Krger, K.; Vlker, K.; Golf, S.; Wadepuhl, M.; Kraus, A. Oral magnesium supplementation reduces insulin resistance in nondiabetic subjects a double blind, placebo controlled, randomized trial. Diabetes Obes. Metab. 2011, 13, 281–284. [CrossRef] [PubMed]
27. Yokota, K.; Kato, M.; Lister, F.; Ii, H.; Hayakawa, T.; Kikuta, T.; Kageyama, S.; Tajima, N. Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J. Am. Coll. Nutr. 2004, 23, 506S–509S. [CrossRef]